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Sexually transmitted disease recurrence in the depart-
ment of defense
A. McCabe ∗, G. Nowak
Navy and Marine Corps Public Health Center, Portsmouth,
VA, USA
Background: Reinfection with chlamydia and gonorrhea is
common; as much as 40% of the reported annual incidence
of these infections occurred in people that had been previ-
ously infected. The objective of this project was to assess
the differences between Department of Defense active duty
personnel that had only one sexually transmitted disease
(STD) and those that had multiple STDs.
Methods: All chlamydia and gonorrhea cases were
extracted from Health Level 7 laboratory data between 01
Oct 2006 and 30 Sept 2008. Positive cases were classiﬁed as
having either one infection or multiple infections during the
study period. Demographic characteristics, treatment pat-
terns and co-morbidities were compared between groups.
Results: There were 30,740 patients with chlamydia or
gonorrhea, 13% (n = 3,954) of whom had more than one
infection. Patients treated for their ﬁrst infection were sig-
niﬁcantly less likely to develop a second infection than
those not treated (z-value = 6.72, df = 1, 99% CI). Signiﬁ-
cantly more patients with multiple infections were treated
than patients with a single infection (z-value = 7.12, df = 1,
99% CI). Related outpatient encounters were identiﬁed for
94% of all cases in patients with multiple STDs.
Conclusion: The majority of patients with multiple infec-
tions had two infections. Reinfection could potentially be
reduced if proper and timely treatment were provided to
patients. Results also suggest additional clinical counseling
may be necessary to prevent or reduce multiple infections.
The study did not identify a speciﬁc demographic popula-
tion with multiple infections that could be targeted for more
speciﬁc intervention.
Disclaimer:
The views expressed in this abstract are those of theauthor and do not necessarily reﬂect the ofﬁcial policy or
position of the Department of the Navy, Department of
Defense, or the U. S. Government.
doi:10.1016/j.ijid.2010.02.538
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ffect of zinc supplementation on clinical course of acute
iarrhea in patients admitted in Ali Asghar Children
ospital Medical Center Iran University of Medical Sci-
ncesTehran Iran
. Mahlouji
Iran University of Medical Sciences, Tehran, Iran, Islamic
epublic of
Background: Pilot studies have been conducted in number
f countries (Brazil, Egypt, Ethiopia, India, Mali, Pak-
stan and Philippines) prior to the implementation of large
ommunity-based studies to introduce zinc in the manage-
ent of acute diarrhea, preliminary results of these studies
how two interesting observations: ORS use rate increase;
ntimicrobial use rate signiﬁcantly decrease with zinc is
rescribed with ORS solution.
Methods: We conducted an interventional study (clinical
rial) in patients who admitted in Ali - Asghar Children Hos-
ital, with one episode of acute diarrhea, the patients were
ivided into two groups(case = 75 and control = 75).
In the case group zinc sulfate was added as supplement.
In control group no supplement was added to usual treat-
ents. Zinc prescribed as zinc sulfate syrup for 14 days
uring and after diarrhea(10mg /day for infants <6 mo of
ge and 20mg / day for those >6 mo of age).
Results: Mean duration time of diarrhea in control group
ithout Zinc Sulfate was 5.63 days and for that of case
roup using zinc sulfate was 3.21 days. Data was analyzed
y SPSS-13 software using T-test and Chi-square Test, there
as a signiﬁcant difference between 2 groups in duration of
iarrhea (P value = 0.001).
Conclusion: In our study prescription of Zinc sulfate in
cute diarrhea similar to other studies reduced the duration
f acute diarrhea. Therefore Zinc Sulfate has an important
ole in treatment of acute diarrhea and should be considered
s a supplement in all cases of diarrhea.
oi:10.1016/j.ijid.2010.02.539
0.002
eonatal tetanus cases in a region in Ghana: Contributory
actors and consequential outcomes
. Koomson
Ghana Health Service, CAPE COAST, Ghana
Background: Immunizing women in fertility aged group
nd pregnant women with tetanus toxiod vaccine is meant
o protect them and their babies against tetanus infection.
rrespective of the prevalence of the vaccination activities
t static and outreach clinics the incidence of neonatal
etanus is usually higher in the Central Region of Ghana
or 2005. This paper throws more lights on factors which
ed to the infection of eight neonates who died within the
ear in a region in Ghana as a result of poor neonatal care,
nvaccinated pregnant women and health seeking behavior
xhibited by the families.
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Methods: Review of hospital admission data of all (8)
eported neonatal cases in 2005 at the Regional Health
irectorate, using multidisciplinary approaches in 2006 by
benezer Koomson.
The records of the cases were veriﬁed at the respective
istricts where they were ﬁrst reported. After accepting the
uthenticity of the cases,then the researchers visited the
ealth facility which attended to each case. The personal
ata and medical history of each neonatal tetanus case was
ssessed to the point of discharge or otherwise. The relatives
f each case were also interviewed. Those who helped or
upervised the delivery were also interviewed to gather the
art each person played in the peri-and neonatal periods of
ach case.
Results: The level of adequate vaccination(receiving at
east two tetanus vaccinations during pregnancy) for the
others was very low (37.5%), four (50%)of the 50% deliver-
es were supervised by skilled health personnel; cord care
as poorer for all the cases with improper observance of
septic techniques, and subsequent death of seven (99%) of
he patients. Fifty percent (50%) of cases were sent to a
ealth facility on the day of onset of the condition. Time-
iness of reporting was 0% (0/8) -none of the cases was
eported to the next upper level timely. The range was
0-180 days. It should have been reported the same day.
ompleteness of reporting was inadequate- (50%) complete.
Conclusion: Adequate number of vaccinations, obser-
ance of aseptic techniques during and after delivery, proper
ealth seeking behavior, health education and effective
eedback of health data is crucial for neonatal care and
urvival.
oi:10.1016/j.ijid.2010.02.540
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ole of adjuvant zinc in the treatment of severe pneu-
onia in young children: A metaanalysis of beneﬁts and
isks
. Das1,∗, M. Singh2, N. Gupta2, N. Shaﬁq2
Post-Graduate Institute of Medical Education and Research
PGIMER), Chandigarh, India
Chandigarh, India
Background: Children with pneumonia have been found
o have lower blood zinc levels as compared to uninfected
hildren. Even in well nourished children suffering from
cute lower respiratory infection, serum zinc levels have
een found to be lower. A recent meta-analysis done on pre-
entive role of zinc in childhood respiratory illness found
igniﬁcant reduction in the frequency and severity of res-
iratory illnesses. However no consensus has evolved for
he therapeutic role of zinc when used as an additive in
reatment of severe pneumonia in young children.
Methods: A comprehensive search was performed of
he major electronic databases (e.g., CENTRAL, MEDLINE,
MBASE, CINAHL) till December 2008. Randomized con-
rolled trials comparing treatment with zinc versus placebo
n children < 5 years with severe pneumonia until discharge
rom hospital were included. Two reviewers independently
pplied eligibility criteria and assessed the studies for
ethodological quality. Data were independently extracted
b
p
1
gternational Congress on Infectious Diseases (ICID) Abstracts
y two reviewers and analyzed using pooled weighted mean
ifference (WMD) or pooled odds ratio (OR) with 95% CI.
evMan version 4.2 was used for all the analyses.
Results: Three Randomized controlled trials (India = 2;
angladesh = 1) (Jadad’s quality score’’ 4) including a total
f 722 subjects were eligible for inclusion. There was no sig-
iﬁcant difference between the two groups in the time of
esolution of severe pneumonia, WMD 1.12 (95% CI -8.17,
0.41; p = 0.81). The duration of hospitalization was signiﬁ-
antly shorter in the control group,WMD 56.28 (95% CI 48.86,
3.70; p < 0.00001). No signiﬁcant difference between the
ntervention and control group was noted for, in the dura-
ion of resolution of tachypnea, chest indrawing, fever and
ypoxia. There was no report of any adverse events.
Conclusion: There is insufﬁcient evidence to recommend
inc for the treatment of severe pneumonia in young chil-
ren < 5 years age. Further studies are required to determine
hether the ﬁndings are reproducible.
oi:10.1016/j.ijid.2010.02.541
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NA ampliﬁcation and sequence analysis of P1 adhesin
ene fragments in M pneumoniae from pediatric respira-
ory infections
. Kumar1,∗, S.R. Saigal 1, G.R. Sethi1, R. Chaudhry2
Maulana AzadMedical College, New Delhi, New Delhi, India
All India Institute of Medical Sciences, New Delhi, New
elhi, India
Background: Mycoplasma pneumoniae is genetically
omogeneous and lacks variation. It possesses a surface-
ocalized protein P1 that clusters at the terminus and
s essential for cytadherence. Direct ampliﬁcation of P1
ene sequences from clinical specimens, bypassing cul-
ure is advocated for subtyping. This study ampliﬁed and
equenced fragment of P1 adhesin gene of M. pneumoniae
mploying nasopharyngeal aspirates (NPA) from children
ith lower respiratory tract infections.
Methods: A total of 276 children aged 2 months to 12
ears, with community acquired lower respiratory tract
nfections (LRTIs) were investigated clinically and radiolog-
cally. An in-house PCR to amplify a 543 base pair fragment
n P1 adhesin gene in M. pneumoniae using NPA was stan-
ardized. PCR products were puriﬁed and sequenced on
utomated DNA analyzer and prototype sequences aligned
nd compared with similar sequences of M. pneumoniae
train M 129 using Clustal W program.
Results: Pneumonia, was documentd in 175(63.3%),
ronchiolitis 90(32.6%), virus associated wheezing 9(3.3%),
neumonia with effusion 2(0.7%) and abnormal chest X —ray
ndings in 191(69.5%) children. Clinical and radiological fea-
ures in M. pneumoniae positive and negative groups were
omparable. Twenty one (7.6%) specimens gave positive
CR; 12(57.3%) specimens yielding weak ampliﬁcation and in
8(89.5%) specimens PCR positive results were reproducible.
equence comparison with Indian strains was not possible
ecause of unavailability of published data whereas com-
arison with M. pneumoniae strain M 129(accession number
8639) using CLUSTAL W (1.83) multiple sequence alignment
ave 98.07% homogeneity with one clinical isolate P-1-1,
